Career
Our solutions
Contact us
Skip to content
About Carasent
Governance
General meeting
Nomination committee
Board of Directors
Management
Remuneration
Auditors
Articles of association
Investor relations
Annual and quarterly reports
Financial calendar
Other documents
The Share
Share buy-back program
Ownership Structure
Relisting to Nasdaq Stockholm 2024
Why invest in Carasent?
Press releases
Career
Our solutions
Contact us
About Carasent
Governance
General meeting
Nomination committee
Board of Directors
Management
Remuneration
Auditors
Articles of association
Investor relations
Annual and quarterly reports
Financial calendar
Other documents
The Share
Share buy-back program
Ownership Structure
Relisting to Nasdaq Stockholm 2024
Why invest in Carasent?
Press releases
Corporate Information
October 22, 2025 - 12:50
Carasent AB (publ) Nomination Committee for the Annual General Meeting 2026
Read more
October 10, 2025 - 10:00
Carasent AB (publ) – Invitation to presentation of Q3 2025 results
Read more
July 7, 2025 - 06:10
Carasent AB (publ): Revised 2025 targets and new medium-term financial targets
Read more
July 4, 2025 - 08:50
Carasent AB (publ) – Invitation to presentation of Q2 2025 results
Read more
April 23, 2025 - 03:12
Annual General Meeting in Carasent AB (publ)
Read more
April 7, 2025 - 03:30
Carasent AB (publ) – Invitation to presentation of Q1 2025 results
Read more
March 24, 2025 - 08:00
Notice of Annual General Meeting in Carasent AB (publ)
Read more
March 21, 2025 - 01:05
The Administrative Court rejects the healthcare providers’ appeal to remove the requirement for Millennium in primary care in VGR
Read more
February 21, 2025 - 01:08
Proposal for election of the board of Carasent AB (publ)
Read more
Load more
